A Single-center, Phase 1 Dose Escalation Study of Trametinib Combined With HDM201 in Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2019
At a glance
- Drugs HDM 201 (Primary) ; Trametinib (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms TRAHD
- 13 Feb 2019 Planned End Date changed from 1 Nov 2020 to 1 Dec 2020.
- 13 Feb 2019 Planned primary completion date changed from 1 Jan 2020 to 1 Feb 2020.
- 13 Feb 2019 Status changed from not yet recruiting to recruiting.